BASEL (dpa-AFX) - GlaxoSmithKline Plc. (GSK, GSK.L) Thursday said at its General Meeting held earlier today, the sole resolution relating to the proposed major transaction with Swiss drugmaker Novartis AG (NVS) was passed by shareholders by an overwhelming majority.
Of the 3.613 billion votes cast, votes for the deal totaled 3.606 billion, and against the deal amounted to 7.67 million.
As previously announced, the transaction is expected to complete during the first half of 2015.
Copyright RTT News/dpa-AFX